Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3 participants
OBSERVATIONAL
2019-10-04
2021-12-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker and Tendril MRI™ Lead
NCT01576016
Safety and Efficacy Study of Tendril MRI™ Leads in Standard Bradycardia Pacing Indication
NCT01528150
EMRI SureScan™ Clinical Study
NCT00433654
Observation of ImageReady™ MR Conditional Pacing System in China
NCT02636712
Safety of Magnetic Resonance Imaging in Non-MRI Conditional Pacemakers and ICD Devices
NCT02906189
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single Arm
Patients implanted with an SJM Tendril STS 2088 or Isoflex 1944/1948 lead, together with an Assurity MRI or Endurity MRI pacemaker, and who will undergo a 3T MRI scan are eligible to participate in this study.
3T MRI scan
A clinically indicated 3T MRI scan will be performed per standard procedures for the radiology department. Cardiac monitoring during the MRI scan is recommended to include Pulse Oximetry and/or ECG.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
3T MRI scan
A clinically indicated 3T MRI scan will be performed per standard procedures for the radiology department. Cardiac monitoring during the MRI scan is recommended to include Pulse Oximetry and/or ECG.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subject must be implanted with a St. Jude Medical Tendril STS 2088 or Isoflex 1944/1948 lead, and Assurity MRI or Endurity MRI pacemaker.
3. Capture threshold is stable and \< 2.5V @ 0.5ms at the time of enrollment.
4. Subject is clinically indicated for a 3T MRI scan without sedation NOTE: Antianxiety agents (e.g. minor tranquilizers, etc.) may be used as long as the patient can communicate with site personnel during the MRI scan
5. Subject is willing and able to comply with the prescribed follow-up tests and schedule of evaluations.
Exclusion Criteria
2. The subject is \<18 years old (pediatric).
3. That subject has a life expectancy of less than 12 months due to any condition.
4. Pregnant or nursing subjects and those who plan pregnancy during the clinical investigation follow-up period.
5. Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements, or impact the scientific soundness of the clinical investigation results.
6. Any contraindication to MRI scan, including the presence of additional hardware (e.g. lead extenders, lead adapters, surgical staples, stents, dental braces, or abandoned leads).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tartu University Hospital
Tartu, , Estonia
Hopital Cardiovasculaire et Pneumologique Louis Pradel
Lyon, Auvergne-Rhône-Alpes, France
CHRU Hopital de Pontchaillou
Rennes, Brittany Region, France
Care Institute of Medical Sciences
Ahmedabad, Gurarat, India
Eternal Haert Care Centre
Jaipur, Rajasthan, India
Apollo Hospital
Chennai, Tamil Nadu, India
AOU Federico II - Università degli Studi di Napoli
Napoli, Campania, Italy
Medisch Centrum Leeuwarden
Leeuwarden, Provincie Friesland, Netherlands
Albert Schweiter Ziekenhuis
Dordrecht, South Holland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ABT-CIP-10266
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.